September 10, 2021

Adagio Therapeutics Announces Expansion of Patient Population in Global Phase 2/3 Clinical Trial of ADG20 for the Prevention of COVID-19

Independent Data Monitoring Committee Supports Expansion to Adolescents and Pregnant and Nursing Women Based on Safety and Tolerability Data from Phase 2 Lead-In WALTHAM, Mass., Sept. 10, 2021 (GLOBE NEWSWIRE) — Adagio Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of antibody-based solutions for infectious

Vaccination campaign for Seychellois children begins Friday

Children in Seychelles between the ages of 12 and 17 will begin receiving their first doses of the Pfizer COVID-19 vaccine on Friday, said a top health official.The Public Health Commissioner, Jude Gedeon, told a press conference Thursday that “parents…